UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 90

Sortiert nach

Genome-wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget's disease of bone

Nature genetics, 2010-06, Vol.42 (6), p.520-524

2010

Volltextzugriff (PDF)

Randomised trial of genetic testing and targeted intervention to prevent the development and progression of Paget's disease of bone

Annals of the rheumatic diseases, 2024-04, Vol.83 (4), p.529

2024

Volltextzugriff (PDF)

SNPs in bone-related miRNAs are associated with the osteoporotic phenotype

Scientific reports, 2017-03, Vol.7 (1), p.516-516, Article 516

2017

Volltextzugriff (PDF)

Epidemiology of Paget's disease of bone: A systematic review and meta-analysis of secular changes

Bone (New York, N.Y.), 2013-08, Vol.55 (2), p.347-352

2013

Volltextzugriff (PDF)

Bisphosphonates for Paget's disease of bone in adults

Cochrane database of systematic reviews, 2017-12, Vol.12 (12), p.CD004956-CD004956

2017

Volltextzugriff (PDF)

Utilidad clínica de los marcadores bioquímicos de remodelado óseo en la mujer posmenopáusica reciente: estudio longitudinal a 2 años

Medicina clínica, 2008-09, Vol.131 (9), p.333-338

2008

Volltextzugriff (PDF)

La enfermedad de Paget: la historia interminable

Reumatología clinica, 2007-03, Vol.3 (1), p.13-17

Pino Montes, Javier del

2007

Volltextzugriff (PDF)

A single infusion of zoledronic acid produces sustained remissions in paget disease: Data to 6.5 years

Journal of bone and mineral research, 2011-09, Vol.26 (9), p.2261-2270

2011

Volltextzugriff (PDF)

Factors associated with long-term retention of treatment with golimumab in a real-world setting: an analysis of the Spanish BIOBADASER registry

Rheumatology international, 2019-03, Vol.39 (3), p.509-515

2019

Volltextzugriff (PDF)

Factors associated with long-term retention of treatment with golimumab in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis: an analysis of the Spanish BIOBADASER registry

Clinical rheumatology, 2021-10, Vol.40 (10), p.3979-3988

2021

Volltextzugriff (PDF)

Polymorphisms in autophagy genes are associated with paget disease of bone

PloS one, 2015-06, Vol.10 (6), p.e0128984-e0128984

2015

Volltextzugriff (PDF)

The next step after anti-osteoporotic drug discontinuation: an up-to-date review of sequential treatment

Endocrine, 2019-06, Vol.64 (3), p.441-455

2019

Volltextzugriff (PDF)

Protección gástrica o protección ósea? El dilema de los inhibidores de la bomba de protones

Revista de osteoporosis y metabolismo mineral, 2015, Vol.7 (4), p.83-84

del Pino Montes, Javier

2015

Volltextzugriff (PDF)

Common susceptibility alleles and SQSTM1 mutations predict disease extent and severity in a multinational study of patients with Paget's disease

Journal of bone and mineral research, 2013-11, Vol.28 (11), p.2338-2346

2013

Volltextzugriff (PDF)

Prevalence of fractures in women with rheumatoid arthritis and/or systemic lupus erythematosus on chronic glucocorticoid therapy

BMC musculoskeletal disorders, 2015-10, Vol.16 (1), p.300-300, Article 300

2015

Volltextzugriff (PDF)

Clinical and therapeutic management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: RADAR study

Rheumatology international, 2019-12, Vol.39 (12), p.2015-2024

2019

Volltextzugriff (PDF)

Zoledronate in the prevention of Paget’s (ZiPP): protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent SQSTM1-mediated Paget’s disease of bone

BMJ open, 2019-09, Vol.9 (9), p.e030689-e030689

2019

Volltextzugriff (PDF)

Características de la enfermedad ósea de Paget en España. Datos del Registro Nacional de Paget

Reumatología clinica, 2009, Vol.5 (3), p.109-114

2009

Volltextzugriff (PDF)

VAV3 Gene Polymorphism Is Associated with Paget's Disease of Bone

Genetic testing and molecular biomarkers, 2016-06, Vol.20 (6), p.335

2016

Volltextzugriff (PDF)

Objetivos y metodología de la fase iii de BIOBADASER

Reumatología clinica, 2019-07, Vol.15 (4), p.229-236

2019

Volltextzugriff (PDF)

SER recommendations on the use of biological drugs in primary Sjögren's syndrome

Reumatología clinica (Barcelona), 2019-11, Vol.15 (6), p.315-326

2019

Volltextzugriff (PDF)

Vitamin D Levels and Lipid Response to Atorvastatin

International Journal of Endocrinology, 2010-01, Vol.2010, p.320721-4

2010

Volltextzugriff (PDF)

1 – 25 von 90

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(75)

Publikationsform

Artikel
(89)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(57)
Life Sciences & Biomedicine
(55)
Humans
(51)
Female
(33)
Rheumatology
(30)
Male
(28)
Middle Aged
(27)
Aged
(23)
Endocrinology & Metabolism
(17)
Adult
(15)
Osteitis Deformans - Genetics
(12)
Biological And Medical Sciences
(11)
Medical Sciences
(10)
Osteoporosis
(10)
Medicine
(9)
Risk Factors
(9)
Aged, 80 And Over
(7)
Cohort Studies
(7)
Diseases Of The Osteoarticular System
(7)
General & Internal Medicine
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Genome-wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget's disease of bone

Randomised trial of genetic testing and targeted intervention to prevent the development and progression of Paget's disease of bone

SNPs in bone-related miRNAs are associated with the osteoporotic phenotype

Epidemiology of Paget's disease of bone: A systematic review and meta-analysis of secular changes

Bisphosphonates for Paget's disease of bone in adults

Utilidad clínica de los marcadores bioquímicos de remodelado óseo en la mujer posmenopáusica reciente: estudio longitudinal a 2 años

La enfermedad de Paget: la historia interminable

A single infusion of zoledronic acid produces sustained remissions in paget disease: Data to 6.5 years

Factors associated with long-term retention of treatment with golimumab in a real-world setting: an analysis of the Spanish BIOBADASER registry

Genome-wide association identifies three new susceptibility loci for Paget's disease of bone

Factors associated with long-term retention of treatment with golimumab in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis: an analysis of the Spanish BIOBADASER registry

Polymorphisms in autophagy genes are associated with paget disease of bone

The next step after anti-osteoporotic drug discontinuation: an up-to-date review of sequential treatment

Protección gástrica o protección ósea? El dilema de los inhibidores de la bomba de protones

Common susceptibility alleles and SQSTM1 mutations predict disease extent and severity in a multinational study of patients with Paget's disease

Prevalence of fractures in women with rheumatoid arthritis and/or systemic lupus erythematosus on chronic glucocorticoid therapy

Clinical and therapeutic management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: RADAR study

Zoledronate in the prevention of Paget’s (ZiPP): protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent SQSTM1-mediated Paget’s disease of bone

Características de la enfermedad ósea de Paget en España. Datos del Registro Nacional de Paget

SER recommendations on the use of biological drugs in primary Sjögren's syndrome

VAV3 Gene Polymorphism Is Associated with Paget's Disease of Bone

Objetivos y metodología de la fase iii de BIOBADASER

Recomendaciones SER sobre la utilización de fármacos biológicos en el síndrome de Sjögren primario

SER recommendations on the use of biological drugs in primary Sjögren's syndrome

Vitamin D Levels and Lipid Response to Atorvastatin

Suchergebnisse filtern